C World Wide Group Holding A Nektar Therapeutics Transaction History

C World Wide Group Holding A

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 12, 2019	SELL	$30.43 - $56.65 $2.46 Million - $4.59 Million	-80,975 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$46.46 - $68.49 $3.76 Million - $5.55 Million	80,975 New	80,975 $4.94 Million

126

109M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $259M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.